What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Kazuyuki Shimada mainly focuses on Internal medicine, Cardiology, Endocrinology, Blood pressure and Ambulatory blood pressure.
His research combines Surgery and Internal medicine.
His Cardiology study incorporates themes from Predictive value of tests and Circadian rhythm.
His work deals with themes such as Inflammation, Interleukin, Thrombomodulin and Pulmonary artery, which intersect with Endocrinology.
His Blood pressure research includes elements of Morning and Central nervous system disease.
His Ambulatory blood pressure research is multidisciplinary, incorporating perspectives in Anesthesia, Cerebral infarction, Microalbuminuria and Intensive care medicine.
His most cited work include:
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis (1827 citations)
- Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives A Prospective Study (1002 citations)
- Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives (609 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Cardiology, Blood pressure, Endocrinology and Ambulatory blood pressure.
The Internal medicine study combines topics in areas such as Gastroenterology and Surgery.
The concepts of his Cardiology study are interwoven with issues in Diabetes mellitus and Circadian rhythm.
His Blood pressure research is multidisciplinary, incorporating elements of Morning, Ambulatory and Anesthesia.
Vascular smooth muscle and Nitric oxide are among the areas of Endocrinology where the researcher is concentrating his efforts.
Lymphoma is the subject of his research, which falls under Pathology.
He most often published in these fields:
- Internal medicine (62.99%)
- Cardiology (35.67%)
- Blood pressure (21.34%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (62.99%)
- Lymphoma (8.66%)
- Blood pressure (21.34%)
In recent papers he was focusing on the following fields of study:
Kazuyuki Shimada mostly deals with Internal medicine, Lymphoma, Blood pressure, Cardiology and Cancer research.
His research on Internal medicine focuses in particular on Hazard ratio.
In Lymphoma, Kazuyuki Shimada works on issues like Epstein–Barr virus, which are connected to CTL*, B symptoms and Survival analysis.
His studies in Blood pressure integrate themes in fields like Morning, Ambulatory and Prospective cohort study.
His work carried out in the field of Cardiology brings together such families of science as Endocrinology, Kidney disease, Left ventricular hypertrophy and Prehypertension.
The various areas that Kazuyuki Shimada examines in his Cancer research study include Immune checkpoint, EZH2 and CD79B.
Between 2013 and 2021, his most popular works were:
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors: A Randomized Clinical Trial (186 citations)
- Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells (132 citations)
- Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study (80 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Internal medicine, Blood pressure, Cancer research, Lymphoma and Cardiology are his primary areas of study.
His research in Internal medicine intersects with topics in Diabetes mellitus, Surgery and Standard treatment.
His Blood pressure research integrates issues from Prospective cohort study and Randomized controlled trial.
Kazuyuki Shimada has included themes like Apoptosis, Programmed cell death, Histone H3 and Primary effusion lymphoma in his Cancer research study.
His Lymphoma research incorporates elements of Hematology, Leukemia and Epstein–Barr virus.
His Cardiology research is multidisciplinary, relying on both Morning, Isolated systolic hypertension, Incidence and Treatment blood.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
